A Study to Evaluate the Safety and Biomarker Effects of RO7269162 in Participants at Risk for or at the Prodromal Stage of Alzheimer's Disease (AD)
Clinical trial NCT06402838 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06402838
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-02
- Primary completion
- 2026-11-19
- Enrollment
- 256
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.